Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Monolithic Laser Combiner

By Drug Discovery Trends Editor | March 26, 2010

agilent-1Agilent Technologies Inc. introduced its monolithic laser combiner system for confocal and fluorescence microscopy applications. The MLC400 monolithic laser combiner brings Agilent’s patented complex monolithic optic (CMO) design technology and proprietary fiber coupling capability into a complete laser illumination solution. The integrated lasers and optics are permanently aligned offering customers optical system stability and ease-of-use. As a result, researchers are able to spend more time doing scientific experimentation and less time maintaining their illumination optics.

“Designed to meet cell biologists’ growing interest in confocal and fluorescence microscopy and their desire to work without fine-tuning their instruments on a frequent basis, the Agilent MLC400 monolithic laser combiner is a fully integrated, permanently aligned, turn-key instrument,” said Bill Volk, Agilent general manager, Nano Positioning Metrology Division. “The monolithic design builds on our expertise in developing extremely reliable optical systems for aerospace, defense and semiconductor applications. The result is an easy-to-use laser illumination system for microscopy that installs in just a few minutes and never requires adjustment to maintain optimal power and alignment.”

With optics bonded in a CMO, the MLC400 monolithic laser combiner delivers stable optical power with superior performance and productivity. Other solutions require the user to make frequent adjustments to many individual optic mounts and lasers to maintain alignment. In the Agilent CMO design, the factory-aligned optical structure will not drift out of alignment due to environmental factors such as temperature changes, vibration or over time. This is a key factor in maintaining stable laser throughput.

Agilent’s MLC400 monolithic laser combiner is ideal for confocal and fluorescence microscopy applications including, total-internal-reflection fluorescence (TIRF), fluorescence resonant-energy transfer (FRET), fluorescence lifetime imaging (FLIM), fluorescence recovery after photobleaching (FRAP), fluorescence in-situ hybridization (FISH) and photo-activated localization microscopy (PALM). The MLC400 is compatible with all major confocal and fluorescence microscope systems.

The standard MLC400 monolithic laser combiner is configured with DPSS and diode lasers at 405nm, 488nm, 561nm, 640nm and an acousto-optic tunable filter (AOTF). A pass-through option allows users to couple alternate laser sources such as argon ion with the system. As research needs change, the instrument can be upgraded to add or change wavelength channels.

Agilent Technologies Inc.


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE